Lazard US Equity Concentrated Portfolio AXSM Holdings History
Lazard US Equity Concentrated Portfolio's Axsome Therapeutics Inc Holding Summary
As of 2025-03-31, LAZARD FUNDS INC held - shares of Axsome Therapeutics Inc(AXSM), totaling N/A. This investment constitutes 0% of their stock portfolio, and LAZARD FUNDS INC now holds 0% of the outstanding Axsome Therapeutics Inc(AXSM) stock.
The initial trade took place in 2024Q4. And since then Lazard US Equity Concentrated Portfolio has made 1 purchases of AXSM, at an average price of $91.98, for a total of 30,433.00 shares. In addition, there have been 1 sales at an average price of $113.93 for 30,433.00 shares. Based on historical transaction data and AXSM's current price of $112.24, Lazard US Equity Concentrated Portfolio's estimated gain on his AXSM holdings is $668,004.35, reflecting a 23.86% gain to date.
Lazard US Equity Concentrated Portfolio AXSM ($112.24) Holding Chart
Lazard US Equity Concentrated Portfolio AXSM ($112.24) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
